insights_auto
Why is ORX down 3.19%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 0.85
arrow_downward
-3.19%(-0.028) 1D
Nov 16, 2:45:47 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.89
High
SEKÂ 0.89
Low
SEKÂ 0.82
Mkt. cap
297.21M
Avg. vol.
777.72K
Volume
342.21K
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.89
High
SEKÂ 0.89
Low
SEKÂ 0.82
Mkt. cap
297.21M
Avg. vol.
777.72K
Volume
342.21K
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
marketscreener.com
·
24 minutes ago
BofA Securities Adjusts Nasdaq Price Target to $135 From $133, Maintains Buy Rating
FXEmpire
·
32 minutes ago
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Barron's
·
1 hour ago
S&P 500 Futures Fall in Premarket Trading; TELUS Corp., Vaxcyte Lead
The Motley Fool
·
1 hour ago
If You Had Invested $10,000 in the Vanguard S&P 500 ETF (VOO) in 2016, Here's What You Would Have Today
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com